Trial NCT02801097

View at ClinicalTrials.gov 
Org. Study IDs: RRx001-16-01

Last trial update was posted on 2022-05-17

MeSH Interventions

Irinotecan

MeSH Conditions

Neoplasms

Other Conditions

Advanced Cancer Malignant Solid Tumor Metastatic Cancer

Stopping Reasons

Sufficient patients enrolled to end study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID